The CIS insulin market is poised for steady growth over the next decade, as rising global diabetes prevalence, advancements in insulin therapies, and government initiatives in diabetes care drive market expansion. The market, valued at USD 506.2 million in 2025, is expected to reach USD 660.7 million by 2035, growing at a compound annual growth rate (CAGR) of 2.7%. https://industrytoday.co.uk/health_and_safety/cis-insulin-market-steady-growth-expected-as-demand-for-diabetes-care-solutions-escalat